SA
ROIV icon

Sanctuary Advisors’s Roivant Sciences ROIV Stock Holding History

Sanctuary Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Buy
+6,880
New +$203K ﹤0.01% 2474

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Sanctuary Advisors's ROIV Position: Q2 2026 in Review

Sanctuary Advisors opened a new position in Roivant Sciences (ROIV) in Q2 2026: 6,880 shares worth $243K. The stake represents ﹤0.01% of the portfolio and ranks #2474 among its holdings.

498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Sanctuary Advisors held 6,880 shares of Roivant Sciences worth $243K as of Q2 2026.
  • Roivant Sciences was a new Sanctuary Advisors position in Q2 2026.
  • Roivant Sciences made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #2474 holding.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.